Cargando…
Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine
Over the last two decades, a large number of non-communicable/chronic disorders reached an epidemic level on a global scale such as diabetes mellitus type 2, cardio-vascular disease, several types of malignancies, neurological and eye pathologies—all exerted system’s enormous socio-economic burden t...
Autores principales: | Zhan, Xianquan, Li, Jiajia, Guo, Yuna, Golubnitschaja, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639411/ https://www.ncbi.nlm.nih.gov/pubmed/34876936 http://dx.doi.org/10.1007/s13167-021-00265-y |
Ejemplares similares
-
Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
por: Qian, Shehua, et al.
Publicado: (2019) -
Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review)
por: Ma, Jessica Yuen Wuen, et al.
Publicado: (2021) -
Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine
por: Guo, Yuna, et al.
Publicado: (2022) -
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine
por: Hagan, Suzanne, et al.
Publicado: (2016) -
Comparison of Different Mass Spectrometry Workflows for the Proteomic Analysis of Tear Fluid
por: Jones, Garrett, et al.
Publicado: (2022)